Clinical Trial

XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors

Name: XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors — clinical trial record (NCT07688577)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a first-in-human, multicenter, Phase 1/2, open-label study designed to evaluate the safety and tolerability of XTX501 as monotherapy in participants with metastatic non-small cell lung cancer (NSCLC) and select advanced solid tumors.

Trial Details

NCT Number	NCT07688577
Lead Sponsor	Xilio Development, Inc.
Conditions	Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor
Enrollment	140 participants
Start Date	2026-08
Primary Completion	2029-11 (estimated)
Study Completion	2029-11 (estimated)
Updated on ClinicalTrials.gov	2026-07-07